NCT06701929 The Impact of Fasting Duration on Quality of Recovery After Cesarean Section
| NCT ID | NCT06701929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jewish General Hospital |
| Condition | Quality Improvement |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-18 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-18 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effect of fasting duration and elective c-section start time on the overall quality of recovery. Patients will be seen 24 hours after surgery to answer 11 questions on their overall recovery after surgery. Several factors will be tracked to determine their effect on recovery, with the primary variable of interesting
Eligibility Criteria
Inclusion Criteria: * Presenting for elective c-section under spinal anesthesia Exclusion Criteria: * Unable to communicate in French or English * Urgent c-section * Planned general anesthesia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06701929 clinical trial?
This trial is open to female participants only, studying Quality Improvement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06701929 currently recruiting?
Yes, NCT06701929 is actively recruiting participants. Contact the research team at matthew.cameron@mcgill.ca for enrollment information.
Where is the NCT06701929 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06701929 clinical trial?
NCT06701929 is sponsored by Jewish General Hospital. The trial plans to enroll 100 participants.